Skip to nav Skip to content

Clinical Trial Search

290 Clinical Trials Found

Clinical Trial 90016

Disease Site: Other Hematopoietic
PI: Sandoval-Sus, Jose

Clinical Trial 23303

Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE)
Disease Site: Prostate
PI: Yamoah, Kosj

Clinical Trial 23363

Disease Site: Non-Hodgkin's Lymphoma
PI: Locke, Frederick

Clinical Trial 22464

Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: A Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)
Disease Site: Thyroid, Head & Neck, Mouth, lip, nasal cavity
PI: Agosto Salgado, Sarimar

Clinical Trial 22196

A First in Human Dose Escalation and Cohort Expansion Study of DLL3-directed Chimeric Antigen Receptor T-cells in Subjects with Extensive Stage Small Cell Lung Cancer
Disease Site: Lung
PI: Chiappori, Alberto

Clinical Trial 22463

SPECT-CT Guided Elective Contralateral Neck Treatment (Select) For Patients With Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial.
Disease Site: Lip, Oral Cavity and Pharynx, Head & Neck, Mouth, lip, nasal cavity
PI: Danan, Deepa

Clinical Trial 17268-B

I-SPY 2.2 TRIAL - Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis 2
Disease Site: Breast
PI: Han, Heather

Clinical Trial 22461

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients with Hematologic Malignancies
Disease Site: Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia
PI: Nishihori, Taiga

Clinical Trial 22333

A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Disease Site: Leukemia, other, Myeloid and Monocytic Leukemia
PI: Komrokji, Rami

Clinical Trial 22306

A Phase 1/2 First-in-Human Study of the Safety and Efficacy of IMC-F106C as a Single Agent and in Combination with Checkpoint Inhibitors in HLA-A*02:01-Positive Participants with Advanced PRAME-Positive Cancers
Disease Site: Any Site
PI: Eroglu, Zeynep

Clinical Trial 21731

A Phase II Trial of Olaparib in Combination with Pembrolizumab for Advanced Uveal Melanoma
Disease Site: Melanoma, skin
PI: Khushalani, Nikhil

Clinical Trial 21854

Disease Site: Lung
PI: Gray, Jhanelle